Logo image of ACVA

ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis

NYSE:ACVA - New York Stock Exchange, Inc. - US00091G1040 - Common Stock - Currency: USD

16.545  -0.21 (-1.28%)

Fundamental Rating

3

Overall ACVA gets a fundamental rating of 3 out of 10. We evaluated ACVA against 83 industry peers in the Commercial Services & Supplies industry. While ACVA seems to be doing ok healthwise, there are quite some concerns on its profitability. ACVA is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ACVA has reported negative net income.
In the past year ACVA had a positive cash flow from operations.
In the past 5 years ACVA always reported negative net income.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
ACVA Yearly Net Income VS EBIT VS OCF VS FCFACVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

ACVA has a worse Return On Assets (-6.43%) than 71.08% of its industry peers.
ACVA has a Return On Equity of -16.85%. This is in the lower half of the industry: ACVA underperforms 63.86% of its industry peers.
Industry RankSector Rank
ROA -6.43%
ROE -16.85%
ROIC N/A
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACVA Yearly ROA, ROE, ROICACVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 52.64%, ACVA belongs to the top of the industry, outperforming 90.36% of the companies in the same industry.
ACVA's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ACVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
ACVA Yearly Profit, Operating, Gross MarginsACVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

4

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACVA has been increased compared to 1 year ago.
ACVA has more shares outstanding than it did 5 years ago.
ACVA has a worse debt/assets ratio than last year.
ACVA Yearly Shares OutstandingACVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACVA Yearly Total Debt VS Total AssetsACVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.42 indicates that ACVA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ACVA (2.42) is comparable to the rest of the industry.
The Debt to FCF ratio of ACVA is 3.12, which is a good value as it means it would take ACVA, 3.12 years of fcf income to pay off all of its debts.
ACVA has a Debt to FCF ratio of 3.12. This is in the better half of the industry: ACVA outperforms 75.90% of its industry peers.
ACVA has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
ACVA has a Debt to Equity ratio of 0.38. This is comparable to the rest of the industry: ACVA outperforms 59.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 3.12
Altman-Z 2.42
ROIC/WACCN/A
WACC8.93%
ACVA Yearly LT Debt VS Equity VS FCFACVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 1.50 indicates that ACVA should not have too much problems paying its short term obligations.
ACVA has a Current ratio (1.50) which is in line with its industry peers.
A Quick Ratio of 1.50 indicates that ACVA should not have too much problems paying its short term obligations.
ACVA has a Quick ratio of 1.50. This is comparable to the rest of the industry: ACVA outperforms 56.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
ACVA Yearly Current Assets VS Current LiabilitesACVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.26% over the past year.
Looking at the last year, ACVA shows a very strong growth in Revenue. The Revenue has grown by 32.90%.
Measured over the past years, ACVA shows a very strong growth in Revenue. The Revenue has been growing by 42.93% on average per year.
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%25.4%

3.2 Future

The Earnings Per Share is expected to grow by 55.66% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACVA will show a very strong growth in Revenue. The Revenue will grow by 20.87% on average per year.
EPS Next Y35.07%
EPS Next 2Y47.53%
EPS Next 3Y48.77%
EPS Next 5Y55.66%
Revenue Next Year22.32%
Revenue Next 2Y22.4%
Revenue Next 3Y23.21%
Revenue Next 5Y20.87%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ACVA Yearly Revenue VS EstimatesACVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
ACVA Yearly EPS VS EstimatesACVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ACVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 195.43, ACVA can be considered very expensive at the moment.
ACVA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ACVA is more expensive than 60.24% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ACVA to the average of the S&P500 Index (21.85), we can say ACVA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 195.43
ACVA Price Earnings VS Forward Price EarningsACVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACVA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 52.91
EV/EBITDA N/A
ACVA Per share dataACVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACVA does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ACVA's earnings are expected to grow with 48.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.53%
EPS Next 3Y48.77%

More info and screens

0

5. Dividend

5.1 Amount

ACVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACV AUCTIONS INC-A

NYSE:ACVA (5/23/2025, 11:55:02 AM)

16.545

-0.21 (-1.28%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners105.03%
Inst Owner Change8.69%
Ins Owners2.1%
Ins Owner Change30.71%
Market Cap2.82B
Analysts84
Price Target22.95 (38.71%)
Short Float %8.18%
Short Ratio4.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.36%
Min EPS beat(2)-9.21%
Max EPS beat(2)23.94%
EPS beat(4)3
Avg EPS beat(4)9.38%
Min EPS beat(4)-9.21%
Max EPS beat(4)23.94%
EPS beat(8)6
Avg EPS beat(8)8.94%
EPS beat(12)10
Avg EPS beat(12)16.96%
EPS beat(16)13
Avg EPS beat(16)18.25%
Revenue beat(2)0
Avg Revenue beat(2)-0.93%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)0.91%
Min Revenue beat(4)-1.63%
Max Revenue beat(4)4.71%
Revenue beat(8)3
Avg Revenue beat(8)0.15%
Revenue beat(12)5
Avg Revenue beat(12)0.48%
Revenue beat(16)8
Avg Revenue beat(16)3.02%
PT rev (1m)-5.92%
PT rev (3m)-9.22%
EPS NQ rev (1m)4.35%
EPS NQ rev (3m)-94.12%
EPS NY rev (1m)0.26%
EPS NY rev (3m)-72.96%
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)-1.73%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)-1.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 195.43
P/S 4.18
P/FCF 52.91
P/OCF 31.68
P/B 6.42
P/tB 28.85
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)0.08
Fwd EY0.51%
FCF(TTM)0.31
FCFY1.89%
OCF(TTM)0.52
OCFY3.16%
SpS3.95
BVpS2.58
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.43%
ROE -16.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.64%
FCFM 7.91%
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 3.12
Debt/EBITDA N/A
Cap/Depr 90.33%
Cap/Sales 5.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z 2.42
F-Score5
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y35.07%
EPS Next 2Y47.53%
EPS Next 3Y48.77%
EPS Next 5Y55.66%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%25.4%
Revenue Next Year22.32%
Revenue Next 2Y22.4%
Revenue Next 3Y23.21%
Revenue Next 5Y20.87%
EBIT growth 1Y17.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year184.71%
EBIT Next 3Y71.06%
EBIT Next 5Y48.03%
FCF growth 1Y316.2%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y12133.2%
OCF growth 3Y-8.47%
OCF growth 5YN/A